Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by MisterBon Dec 22, 2009 3:58pm

490 Views

Post# 16611873

RE: RE: RE: Why

Great news today. I happened to sell 1k and hold 1k and I think this will be a great trading stock with YA involved... just need to be careful not to "baghold" and try to by when YA stops selling their converted shares. The problem with that is that it is a guessing game. No one knows the shareprice conversion and quantity, but will feel it...

Will likely sell my other 1k tomorrow or as soon as I see this spike stop.

Good luck folks,

B

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week